Chaozhuo Y. Li

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Radiotherapy after Neoadjuvant Immunochemotherapy in Unresectable Stage III Non-Small Cell Lung Carcinoma: A Novel Therapeutic Approach?

Radiotherapy after Neoadjuvant Immunochemotherapy in Unresectable Stage III Non-Small Cell Lung Carcinoma: A Novel Therapeutic Approach?

Journal: Precision radiation oncology

Published: January 14, 2025

Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy.

Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: August 06, 2024

Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients.

Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients.

Journal: International immunopharmacology

Published: February 04, 2024

Dysfunction of CD8+ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients.

Dysfunction of CD8+ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients.

Journal: Cancer science

Published: January 04, 2024

Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.

Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: November 05, 2023

Spatial features of specific CD103+CD8+ tissue-resident memory T cell subsets define the prognosis in patients with non-small cell lung cancer.

Spatial features of specific CD103+CD8+ tissue-resident memory T cell subsets define the prognosis in patients with non-small cell lung cancer.

Journal: Journal of translational medicine

Published: August 09, 2023

Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.

Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.

Journal: Journal of translational medicine

Published: February 24, 2023

Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study.

Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study.

Journal: Journal of thoracic disease

Published: November 23, 2022

Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study.

Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study.

Journal: Journal of neuro-oncology

Published: September 17, 2022

Study on the relationship between ABCB1 gene polymorphism and hemorrhage risk after thrombolysis of cerebral ischemic stroke in Shangqiu area

Study on the relationship between ABCB1 gene polymorphism and hemorrhage risk after thrombolysis of cerebral ischemic stroke in Shangqiu area

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: July 25, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026